Usages in wwPDB of concept: c_0376
nUsages: 113; SSE string: HHHHHHHH
1af3:A     (SER4) to   (LEU194)  RAT BCL-XL AN APOPTOSIS INHIBITORY PROTEIN  |   BCL-XL, APOPTOSIS, MITOCHONDRION, ALTERNATIVE SPLICING, REGULATORY PROTEIN 
4wmu:A   (LEU174) to   (HIS320)  STRUCTURE OF MBP-MCL1 BOUND TO LIGAND 2 AT 1.55A  |   APOPTOSIS, PROTEIN-PROTEIN INTERACTION 
4hw4:B   (GLY203) to   (PHE319)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   ANTI-APOPTOTIC PROTEIN, BH3 PEPTIDES, APOPTOSIS 
2pqk:A   (LEU174) to   (HIS320)  X-RAY CRYSTAL STRUCTURE OF HUMAN MCL-1 IN COMPLEX WITH BIM BH3  |   BCL-2 FAMILY, BH3 DOMAIN, APOPTOSIS 
3spf:A     (GLN3) to   (LEU194)  CRYSTAL STRUCTURE OF BCL-XL BOUND TO BM501  |   BCL-2-LIKE PROTEIN, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX, APOPTOSIS REGULATOR-INHIBITOR COMPLEX 
1pq0:A     (SER2) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL  |   BCL-XL, APOPTOSIS 
2roc:A   (ASP154) to   (VAL302)  SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH PUMA  |   MCL-1, BCL-2, APOPTOSIS, PUMA, BH3-ONLY, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION 
2rod:A   (GLU152) to   (ASP304)  SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAA  |   MCL-1, NOXAA, APOPTOSIS, BH3-ONLY, BCL-2, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION 
1r2d:A     (GLN3) to   (LEU194)  STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS  |   APOPTOSIS, MONOMERIC, ALPHA-HELICAL 
1r2e:A     (SER2) to   (LEU194)  HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT POSITION 92  |   APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION 
1r2g:A     (SER2) to   (LEU194)  HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT POSITION 97  |   APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION 
1r2i:A     (GLN3) to   (LEU194)  HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT POSITION 146  |   APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION 
4k5a:A    (ASP20) to   (LEU161)  CO-CRYSTALLIZATION WITH CONFORMATION-SPECIFIC DESIGNED ANKYRIN REPEAT PROTEINS EXPLAINS THE CONFORMATIONAL FLEXIBILITY OF BCL-W  |   APOPTOSIS, ANTI-APOPTOTIC BCL-2 FAMILY, BCL-W;CRYSTAL STRUCTURE, LIGAND BINDING-COMPETENT CONFORMATION, DARPINS 
4zbi:A   (GLY203) to   (HIS320)  MCL-1 COMPLEXED WITH SMALL MOLECULES  |   INHIBITOR, COMPLEX 
4zbi:C   (GLY203) to   (PHE319)  MCL-1 COMPLEXED WITH SMALL MOLECULES  |   INHIBITOR, COMPLEX 
2vm6:A     (SER0) to   (GLU149)  HUMAN BCL2-A1 IN COMPLEX WITH BIM-BH3 PEPTIDE  |   B-CELL LYMPHOMA2, ANTIAPOPTOTIC, IMMUNE SYSTEM, BIM, BFL-1, BCL2A1, BCL-2A1, MEMBRANE, APOPTOSIS 
2vof:A     (SER0) to   (GLU149)  STRUCTURE OF MOUSE A1 BOUND TO THE PUMA BH3-DOMAIN  |   BH3, BCL-2, APOPTOSIS, PRO-SURVIVAL, MITOCHONDRION, PROTEIN-PROTEIN COMPLEX 
2voi:A     (SER0) to   (PHE148)  STRUCTURE OF MOUSE A1 BOUND TO THE BID BH3-DOMAIN  |   PROTEIN-PROTEIN COMPLEX, BH3, BCL-2, MEMBRANE, APOPTOSIS, PRO-SURVIVAL, MITOCHONDRION, PHOSPHOPROTEIN 
2vog:A     (MET1) to   (GLU149)  STRUCTURE OF MOUSE A1 BOUND TO THE BMF BH3-DOMAIN  |   PROTEIN-PROTEIN COMPLEX, BH3, BCL-2, APOPTOSIS, PRO-SURVIVAL 
2voh:A     (MET1) to   (PHE148)  STRUCTURE OF MOUSE A1 BOUND TO THE BAK BH3-DOMAIN  |   BH3, BCL-2, MEMBRANE, APOPTOSIS, PRO-SURVIVAL, TRANSMEMBRANE, PROTEIN-PROTEIN COMPLEX 
3ihc:A     (SER2) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL (WT) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ihd:A     (HIS0) to   (TYR195)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (Y101A) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ihe:A     (GLN3) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (F105A) AT PH 6.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ihf:A     (SER4) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ihf:B     (GLN3) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ihf:C     (SER4) to   (TYR195)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ihf:D     (GLN3) to   (TYR195)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3iig:A     (GLN3) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (F105A) AT PH 5.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3iih:A     (SER2) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL (WT) AT PH 6.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3ilc:A     (HIS0) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (Y101A) AT PH 6.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, ALTERNATIVE SPLICING, CYTOPLASM, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
3io9:A   (ASP172) to   (PHE319)  BIML12Y IN COMPLEX WITH MCL-1  |   APOPTOSIS, ALTERNATIVE SPLICING, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ISOPEPTIDE BOND, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION 
1ty4:A    (ILE80) to   (ARG237)  CRYSTAL STRUCTURE OF A CED-9/EGL-1 COMPLEX  |   APOPTOSIS, CED-9, EGL-1, BCL-2 FAMILY PROTEINS, RECOGNITION 
4lvt:A     (ASN9) to   (TYR199)  BCL_2-NAVITOCLAX (ABT-263) COMPLEX  |   8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX 
4lvt:B     (ASN9) to   (TYR199)  BCL_2-NAVITOCLAX (ABT-263) COMPLEX  |   8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX 
4lxd:A     (ASN9) to   (LEU198)  BCL_2-NAVITOCLAX ANALOG (WITHOUT THIOPHENYL) COMPLEX  |   8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX 
5agw:B    (GLU13) to   (TYR202)  BCL-2 ALPHA BETA-1 COMPLEX  |   BCL-2, FOLDAMER, BIM, APOPTOSIS 
3wiy:A   (LEU174) to   (PHE319)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10  |   REGULATION, APOPTOSIS 
3wiy:C   (GLU173) to   (PHE319)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10  |   REGULATION, APOPTOSIS 
3wiy:E   (GLY203) to   (PHE319)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10  |   REGULATION, APOPTOSIS 
3wiy:F   (GLU173) to   (HIS320)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10  |   REGULATION, APOPTOSIS 
2jm6:B   (GLU152) to   (PHE299)  SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAB  |   APOPTOSIS, MCL-1, BCL-2, HELICAL BUNDLE, BH3-ONLY 
2k7w:A    (GLU17) to   (TYR164)  BAX ACTIVATION IS INITIATED AT A NOVEL INTERACTION SITE  |   BAX, BIM, BH3, BCL-2, APOPTOSIS 
2kua:A     (LEU8) to   (LYS159)  SOLUTION STRUCTURE OF A DIVERGENT BCL-2 PROTEIN  |   BOO, DIVA, BCL-2, APOPTOSIS, BH3-ONLY, MEMBRANE, MITOCHONDRION, NUCLEUS, TRANSMEMBRANE 
1wsx:A   (LEU155) to   (PHE299)  SOLUTION STRUCTURE OF MCL-1  |   HELICAL BUNDLE, APOPTOSIS, BCL-2, BH3, MCL-1 
2lpc:A     (GLN3) to   (TYR155)  NMR STRUCTURE OF BCL-XL  |   APOPTOSIS, APOPTOSIS INHIBITOR 
5c3f:A   (SER172) to   (HIS320)  CRYSTAL STRUCTURE OF MCL-1 BOUND TO BID-MM  |   COMPLEX, BCL-2 FAMILY, BH3, STAPLED PEPTIDE, APOPTOSIS 
2lr1:A    (GLU17) to   (PHE165)  STRUCTURAL MECHANISM FOR BAX INHIBITION BY CYTOMEGALOVIRUS PROTEIN VMIA  |   APOPTOSIS-SIGNALING PROTEIN COMPLEX 
2mhs:A     (ASP3) to   (HIS151)  NMR STRUCTURE OF HUMAN MCL-1  |   MCL-1, BCL-2 FAMILY, BH DOMAIN, APOPTOSIS, CANCER DRUG, GFT NMR 
5c6h:G   (GLY203) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:I   (ASP172) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:K   (SER202) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:M   (GLY203) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:O   (ALA204) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:Q   (SER206) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:S   (GLU173) to   (PHE319)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5c6h:W   (ASP172) to   (HIS320)  MCL-1 COMPLEXED WITH MULE  |   COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
2nl9:A   (ASP172) to   (PHE319)  CRYSTAL STRUCTURE OF THE MCL-1:BIM BH3 COMPLEX  |   APOPTOSIS, BCL-2, MCL-1, BIM 
2nla:A   (ASP172) to   (HIS320)  CRYSTAL STRUCTURE OF THE MCL-1:MNOXAB BH3 COMPLEX  |   APOPTOSIS, BCL-2, MCL-1, NOXA 
2yxj:B     (SER4) to   (LEU194)  CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH ABT-737  |   APOPTOSIS, CANCER THERAPEUTIC 
2o2m:A     (GLN7) to   (LEU198)  SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND  |   APOPTOSIS, COMPLEX, BCL, NMR 
4oq5:E   (MET172) to   (PHE319)  CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-(4- METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)SULFONYL]AMINO}BENZOIC ACID  |   APOPTOSIS-INHIBITOR COMPLEX 
1maz:A     (MET1) to   (LEU194)  X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH  |   APOPTOSIS, PROGRAMMED CELL DEATH, BCL-2 FAMILY 
3kj0:A   (SER202) to   (HIS320)  MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DY  |   BCL-2, BH3, APOPTOSIS, PROTEIN-PEPTIDE COMPLEX, ALTERNATIVE SPLICING, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ISOPEPTIDE BOND, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION 
3kj2:A   (GLY203) to   (HIS320)  MCL-1 IN COMPLEX WITH BIM BH3 MUTANT F4AE  |   BCL-2, BH3, APOPTOSIS, PROTEIN-PEPTIDE COMPLEX, ALTERNATIVE SPLICING, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ISOPEPTIDE BOND, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION 
3kz0:A   (GLY203) to   (HIS320)  MCL-1 COMPLEX WITH MCL-1-SPECIFIC SELECTED PEPTIDE  |   BCL-2, BH3, MITOCHONDRION, APOPTOSIS, ANTI-APOPTOTIC 
1ysw:A     (ASP8) to   (GLY200)  SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND  |   COMPLEX, APOPTOSIS 
4aq3:A    (ASN11) to   (TYR161)  HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR  |   APOPTOSIS, CHIMERA 
4aq3:D    (ASP10) to   (TYR161)  HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR  |   APOPTOSIS, CHIMERA 
4aq3:E    (ASN11) to   (LEU160)  HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR  |   APOPTOSIS, CHIMERA 
4aq3:F    (ASP10) to   (GLY162)  HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR  |   APOPTOSIS, CHIMERA 
4qnq:A     (SER2) to   (ASN197)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263  |   ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
4qnq:E     (MET1) to   (GLY196)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263  |   ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
4qnq:I     (MET1) to   (GLY196)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263  |   ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
4qnq:J     (GLN3) to   (ASN197)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263  |   ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
4qnq:L     (MET1) to   (TYR195)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263  |   ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
3mk8:A   (ASP172) to   (HIS320)  THE MCL-1 BH3 HELIX IS AN EXCLUSIVE MCL-1 INHIBITOR AND APOPTOSIS SENSITIZER  |   MCL-1, MCL-1 SAHB D, STAPLE, SAHB, BCL-2 FAMILY, APOPTOSIS, ANTI- APOPTOTIC, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
4bpi:A   (ASP172) to   (PHE319)  MCL-1 BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 2  |   APOPTOSIS, CHIMERA, BIM 
4bpj:A   (ASP172) to   (PHE319)  MCL-1 BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 3  |   APOPTOSIS, CHIMERA, BIM 
5fdr:A   (GLY203) to   (HIS320)  MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR  |   MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
5fdr:C   (ASP172) to   (PHE319)  MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR  |   MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
4s0o:B    (SER15) to   (GLY166)  CRYSTAL STRUCTURE OF THE AUTOINHIBITED DIMER OF PRO-APOPTOTIC BAX (I)  |   BCL-2 FAMILY PROTEIN, APOPTOSIS REGULATOR, AUTOINHIBITED DIMER, APOPTOSIS 
3d7v:A   (ASP172) to   (HIS320)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH AN MCL-1 SELECTIVE BH3 LIGAND  |   HELICAL BUNDLE, AMPHIPATHIC HELIX, ALTERNATIVE SPLICING, APOPTOSIS, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION 
3pk1:A   (SER173) to   (PHE319)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH THE BAXBH3 DOMAIN  |   BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
3pk1:C   (SER173) to   (PHE319)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH THE BAXBH3 DOMAIN  |   BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
3pl7:A     (SER4) to   (LEU194)  CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BAXBH3 DOMAIN  |   BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
3pl7:B     (SER4) to   (TYR195)  CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BAXBH3 DOMAIN  |   BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX 
5jsb:A   (GLU173) to   (PHE319)  CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX  |   MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX 
5jsb:C   (THR205) to   (PHE319)  CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX  |   MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX 
5jsb:E   (SER202) to   (PHE319)  CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX  |   MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX 
5jsb:G   (LEU174) to   (PHE319)  CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX  |   MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX 
5jsb:I   (GLU173) to   (PHE319)  CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX  |   MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX 
5jsb:K   (ASP172) to   (PHE319)  CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX  |   MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX 
5lof:A   (LEU174) to   (HIS320)  CRYSTAL STRUCTURE OF THE MBP-MCL1 COMPLEX WITH HIGHLY SELECTIVE AND POTENT INHIBITOR OF MCL1  |   APOPTOSIS-INHIBITOR COMPLEX, MCL-1, S S63845, MBP 
4wmv:A   (LEU174) to   (HIS320)  STRUCTURE OF MBP-MCL1 BOUND TO LIGAND 4 AT 2.4A  |   APOPTOSIS, PROTEIN-PROTEIN INTERACTION 
4hw2:D   (GLU173) to   (PHE319)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw2:E   (GLY171) to   (PHE319)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw2:F   (GLU173) to   (HIS320)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw3:H   (ASP172) to   (PHE319)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw3:I   (LEU174) to   (HIS320)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw3:J   (GLU173) to   (HIS320)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw3:K   (GLU173) to   (VAL321)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
4hw3:L   (GLU173) to   (PHE319)  DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN  |   REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX 
1r2h:A     (MET1) to   (LEU194)  HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT POSITION 142  |   APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION 
4zbf:H   (GLU173) to   (PHE319)  MCL-1 COMPLEXED WITH SMALL MOLECULES  |   INHIBITOR, COMPLEX 
3ilb:N     (GLN3) to   (LEU194)  CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 6.0  |   APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE 
4man:B     (ASN9) to   (LEU198)  BCL_2-NAVITOCLAX ANALOG (WITH INDOLE) COMPLEX  |   8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX 
3wix:D   (GLY203) to   (PHE319)  CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 4  |   REGULATION, APOPTOSIS 
2kbw:A   (GLU173) to   (PHE319)  SOLUTION STRUCTURE OF HUMAN MCL-1 COMPLEXED WITH HUMAN BID_BH3 PEPTIDE  |   MCL-1, BID_BH3, COMPLEX, ALTERNATIVE SPLICING, APOPTOSIS, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION 
2o21:A     (ASP8) to   (GLY200)  SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND  |   APOPTOSIS, COMPLEX, BCL, NMR 
3mqp:A     (GLY7) to   (GLU149)  CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH NOXA BH3 PEPTIDE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR2930  |   BCL-2 FAMILY, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, APOPTOSIS 
5fdo:C   (LEU174) to   (HIS320)  MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR  |   MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
5fdo:D   (GLU173) to   (HIS320)  MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR  |   MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX 
5jsn:A    (ASN11) to   (TYR202)  BCL2-INHIBITOR COMPLEX  |   BCL-2, ANTIBCL2, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX